Adela, Inc.
Advancing the field of epigenomics to transform how cancer is detected and monitored.
70 employees · est. 2020 · Foster City, United States
Geneseeq Technology Inc. is the older company (2020 vs 2012); Adela, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Adela, Inc. | Geneseeq Technology Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2012 older |
| Headquarters | ||
| Headquarters | Foster City, United States | Toronto, Canada |
| Employees | ||
| Employees | 70 larger | 32 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Unknown | Series D |
| Total Funding | ||
| Total Funding | $108.00M | $940.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | Developing best-in-class technology for cancer diagnosis through blood tests, Scalable platform for detecting minimal residual disease, Monitoring response in patients receiving immunotherapy, Screening and early detection of multiple types of cancer | Central Lab Testing, Local Testing Solutions, IVD Kit Solutions, RUO Kit Solutions, Research Services, DNA Sequencing, RNA Sequencing, Project Management, Data Analysis, Sample Logistics and Storage, Customized QC/QA Solutions |
| Target Customers | ||
| Target Customers | Oncologists, Cancer treatment centers, Healthcare providers, Researchers and scientists in oncology, Patients undergoing cancer treatment | Oncologists, Physicians, Researchers, Pharma/Biopharma Companies, Biotechnology Firms, Hospitals, Research Institutions, Distributors, Lab Services |
| Taxonomy | ||
| Taxonomy | Blood-based Diagnostics, Cancer Detection, Early Disease Detection, Methylation Enrichment Technology, Genomic Analysis, Biomarker Discovery, Precision Oncology, Liquid Biopsy, Genome-wide Methylome, Cancer Continuum, Health Technology, Disease Management, Molecular Diagnostics, High-morbidity Conditions, Cancer Care Innovation | Precision Oncology, Next-Generation Sequencing, Cancer Detection, In Vitro Diagnostics, Research Use Only Testing, Pan-Cancer Panels, Cancer-Specific Panels, Minimal Residual Disease Monitoring, Multi-Cancer Early Detection, Tumor Mutational Burden Testing, Biomarker Discovery, Translational Research, Companion Diagnostics, Personalized Medicine, Clinical Genomics |
| Website | ||
| Website | adelabio.com | na.geneseeq.com |
About Adela, Inc.
Adela, Inc. is poised to revolutionize cancer care through its transformative blood testing technology. With the compelling slogan, "Imagine a world in which a single blood draw can be used to detect and enable early treatment of many different diseases," Adela is committed to leveraging biology to...
About Geneseeq Technology Inc.
Geneseeq Technology Inc. is a pioneering force in the field of precision oncology, leveraging next-generation sequencing (NGS) technologies to revolutionize cancer detection, diagnosis, and treatment. Operating from dual headquarters in Canada and China, the company upholds rigorous quality standard...
We will tell you when either one moves
BounceWatch watches Adela, Inc. and Geneseeq Technology Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Adela, Inc. and Geneseeq Technology In... — by email.
Frequently Asked Questions
Compare Adela, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Adela, Inc. on 9 Jun 2026, and Geneseeq Technology Inc. on 11 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.